Seres Therapeutics (MCRB) Interest Coverage Ratio: 2020-2024
Historic Interest Coverage Ratio for Seres Therapeutics (MCRB) over the last 3 years, with Mar 2024 value amounting to -55.72.
- Seres Therapeutics' Interest Coverage Ratio fell 53.83% to -55.72 in Q1 2024 from the same period last year, while for Mar 2024 it was -8.72, marking a year-over-year increase of 68.42%. This contributed to the annual value of -79.05 for FY2023, which is 164.51% down from last year.
- According to the latest figures from Q1 2024, Seres Therapeutics' Interest Coverage Ratio is -55.72, which was down 458.60% from 15.54 recorded in Q2 2023.
- Over the past 5 years, Seres Therapeutics' Interest Coverage Ratio peaked at 91.94 during Q3 2021, and registered a low of -66.98 during Q4 2021.
- In the last 3 years, Seres Therapeutics' Interest Coverage Ratio had a median value of -36.23 in 2023 and averaged -30.70.
- Data for Seres Therapeutics' Interest Coverage Ratio shows a peak YoY increase of 323.77% (in 2021) and a maximum YoY decrease of 184.05% (in 2021) over the last 5 years.
- Seres Therapeutics' Interest Coverage Ratio (Quarterly) stood at -23.58 in 2020, then crashed by 184.05% to -66.98 in 2021, then spiked by 98.63% to -0.92 in 2022, then soared by 136.83% to 15.54 in 2023, then plummeted by 53.83% to -55.72 in 2024.
- Its Interest Coverage Ratio was -55.72 in Q1 2024, compared to 15.54 in Q2 2023 and -36.23 in Q1 2023.